- Home
Presenter Disclosures
Disclosures are for anything of value received from a commercial interest* or financial relationship** which relates directly or indirectly to the subject of a presentation. All conference presenters are required to declare any financial or industry disclosures during the submission process. Having an interest in or an affiliation with a corporate organization may or may not prevent a speaker from making a presentation. ILCA must be made aware of the relationship in advance.
Circumstances create a conflict of interest when a speaker has an opportunity to affect presentation content about products or services of a commercial interest with which the speaker has a financial relationship.
ILCA will not approve education that is not International Code of Marketing of Breast-milk Substitutes compliant. We require our speakers to state their compliance with the International Code. Should any speaker be found in violation of the International Code, ILCA reserves the right to cancel the presentation and the speaker’s involvement with conference activities and nullify prior agreements.
All speakers must state their disclosures verbally and include them in writing on the disclosure slide at the beginning of their presentation.
When potential conflicts of interest are disclosed that cannot be easily resolved, ILCA’s Compliance Team or the International Code Committee will review the situation and make the final decision on whether the presentation will be included in the program.
*A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.**A relevant financial relationship is a financial relationship in any amount occurring within the past 12 months that creates a conflict of interest.
Presenters with No Disclosures
The following presenters have indicated they have no significant financial interest or other relations with the manufacturer(s) of any product(s) or provider(s) of any services they intend to discuss relating to the subject matter of their presentations.
Ayah Al Far
Siti Mariam Ali
Jackeline Ashiyama
Ivy Bagley
Holly Beck
Marie-Caroline Bergouignan
Deborah Bucsh
Suzanne Campbell
Nina Chad
Ayisha Chandni
Jayne Charlamb
Crystal Cooper
Joan Dodgson
静 袁
Adrienne Fuson
Linda Goldman |
Taghreed Hawsawi
Shela Hirani
Hamizah Ismail
Nurjasmine Aida Jamani
Wafa Khasawneh
Robin LaGrandeur
Sonia Lai
Annabelle Mackenzie
Sally Mahmoud
Carrie Miller
Davia Moss
Samira Moughrabi
Mariana Oliveira
Rebecca Powell
Janet Regts |
Aubrey Richardson
Shyamala Sathiaseelan
Sonia Semenic
Kathy Shats
Kendra Shelby
Natalie Shenker
Linda Smith
Samah Soliman
Syed Abdul Khaliq Syed Abd Hamid
Hairin Anisa Tajuddin
Angela Tatum Malloy
Cecilia Tomori
Maryelena Vargas
Elaine Webber
Nadine Wodwaski |
Presenters with Commercial Disclosures
The following presenters have indicated the following financial interest or other relationship with a manufacturer and/or provider:
Cathy Carothers has received CHAMPS grants to assist with IPE promotion
Kristina Chamberlain is employed by the University of California San Diego Extension program mentioned in the presentation
Saray Hill receives and employee salary from IBLCE
Nekisha Killings is the creator/owner of the The Melanated Mammary Atlas®, a professional resource that will be a source of images in
the presentation
Sara Lake receives and employee salary from IBLCE
Janice Tedder is the president and CEO of HUG Your Baby
Kristin Tully would like to disclose as the inventor of a patented medical device (postnatal unit bassinet) in addition to being the founder
and Chief Scientist at Couplet Care, LLC from which a salary is not received but equity in the company is held |
Presenters with FDA Clearance Disclosures
The following presenters have indicated the use of pharmaceuticals and/or medical devices:
Siti Mariam Ali - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation.
Ivy M. Bagley - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation.
Jayne R. Charlamb - The FDA has not cleared all pharmaceuticals and/or medical devices for the use described in this presentation.
Taghreed Hawsawi - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation.
Davia Moss - The FDA has not cleared all pharmaceuticals and/or medical devices for the use described in this presentation.
Kendra L. Shelby - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation.
Hairin Anisa Tajuddin - The FDA has cleared all pharmaceuticals and/or medical devices for the use described in this presentation. |
Conference Disclaimer
Statements of fact or opinion expressed by presenters are solely the responsibility of those presenters. ILCA does not assume responsibility for the accuracy of the material and such material does not represent the official policy, opinion, recommendation, or endorsement of ILCA. The appearance and content of advertisements contained in the final program or registration inserts do not constitute a guarantee or an endorsement of the quality or value of the advertised products or services or of the claims made for them by their advertisers.
